Acadia Pharmaceuticals
ACAD
ACAD
142 hedge funds and large institutions have $2.18B invested in Acadia Pharmaceuticals in 2013 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 46 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
11% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 46
Holders
142
Holding in Top 10
8
Calls
$373M
Puts
$26.2M
Top Buyers
| 1 | +$56.6M | |
| 2 | +$47M | |
| 3 | +$26.2M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$15.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$13.3M |
Top Sellers
| 1 | -$123M | |
| 2 | -$40.6M | |
| 3 | -$26.9M | |
| 4 |
VAM
Visium Asset Management
New York
|
-$21.4M |
| 5 |
DM
Deerfield Management
New York
|
-$19.4M |